US20080161335A1 - Oral formulations - Google Patents

Oral formulations Download PDF

Info

Publication number
US20080161335A1
US20080161335A1 US11/985,094 US98509407A US2008161335A1 US 20080161335 A1 US20080161335 A1 US 20080161335A1 US 98509407 A US98509407 A US 98509407A US 2008161335 A1 US2008161335 A1 US 2008161335A1
Authority
US
United States
Prior art keywords
ap23573
solution
antioxidant
solid
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/985,094
Inventor
Ronald S. Vladyka
David C. Dalgarno
John D. Iuliucci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ARIAD Pharmaceuticals Inc
Original Assignee
ARIAD Gene Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US85887006P priority Critical
Application filed by ARIAD Gene Therapeutics Inc filed Critical ARIAD Gene Therapeutics Inc
Priority to US11/985,094 priority patent/US20080161335A1/en
Assigned to ARIAD GENE THERAPEUTICS, INC. reassignment ARIAD GENE THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: IULIUCCI, JOHN D., DALGARNO, DAVID C., VLADYKA, JR., RONALD S.
Publication of US20080161335A1 publication Critical patent/US20080161335A1/en
Assigned to ARIAD PHARMACEUTICALS, INC. reassignment ARIAD PHARMACEUTICALS, INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: ARIAD GENE THERAPEUTICS, INC.
Application status is Abandoned legal-status Critical

Links